Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Seribantumab (Synonyms: SAR-256212, SAR256212, MM-121, MM121)

Catalog No. T76791 Copy Product Info
🥰Excellent
Seribantumab (MM 121) is a humanized monoclonal antibody targeting HER3, inhibiting NRG1-induced growth in MCF-7 cells and patient-derived breast and lung cancer cells harboring NRG1 fusions or amplifications. It also induces apoptosis in MDA-MB-175-VII and LUAD-0061AS3 cells.

Seribantumab

Copy Product Info
🥰Excellent
Catalog No. T76791
Synonyms SAR-256212, SAR256212, MM-121, MM121

Seribantumab (MM 121) is a humanized monoclonal antibody targeting HER3, inhibiting NRG1-induced growth in MCF-7 cells and patient-derived breast and lung cancer cells harboring NRG1 fusions or amplifications. It also induces apoptosis in MDA-MB-175-VII and LUAD-0061AS3 cells.

Seribantumab
Cas No. 1334296-12-6
TargetMol | Customer service
Customer service consultation
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$78In StockIn Stock
5 mg$237In StockIn Stock
10 mg$383-In Stock
25 mg$629-In Stock
50 mg$889-In Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:96.26% (SEC-HPLC)
Appearance:Liquid
Color:Transparent
Contact us for more batch information

Product Introduction

Bioactivity
Description
Seribantumab (MM 121) is a humanized monoclonal antibody targeting HER3, inhibiting NRG1-induced growth in MCF-7 cells and patient-derived breast and lung cancer cells harboring NRG1 fusions or amplifications. It also induces apoptosis in MDA-MB-175-VII and LUAD-0061AS3 cells.
Targets&IC50
HBECp53 cell:203 μM, MDA-MB-175-VII cells:0.02 μM, LUAD-0061AS3 cell:1.4 μM, MCF-7 cells:45.2 μM
In vitro
Methods: seribantumab (0.1, 1, 10 μM) was used to treat cancer cells.
Results: seribantumab inhibited neuregulin (NRG1) fusion dependent tumorigenosis.
The IC50 values of Seribantumab for MDA-MB-175-VII cells, LUAD-0061AS3 cells, MCF-7 cells, and HBECp53 cells were 0.02 μM, 1.4 μM, 45.2 μM, and 203 μM, respectively. [1]
In vivo
Seribantumab (0.6 mg, 0.75 mg, or 1 mg per dose twice weekly) was injected into mice with LUAD-0061AS3 PDX tumors, and results showed that seribantumab was more effective than afatinib in reducing tumor growth. [1]
SynonymsSAR-256212, SAR256212, MM-121, MM121
Reactivity
Human
Verified Activity
Immobilized Human HER3 Protein (His) at 2 μg/mL (30 μL/well) can bind Seribantumab. The EC50 is 0.01214 μg/mL.
verifiedActivity
Application
Functional assay
Antibody Type
Monoclonal
FormulationSupplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition.
Endotoxin<1.0 EU/mg
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
Gene ID
Uniprot ID
TargetERBB3/HER3
Chemical Properties
Molecular Weight143.14 kDa
Cas No.1334296-12-6
Antibody Information
IsotypeHuman IgG2 lambda
Recommended Isotype Control
Storage & Solubility Information
Storagestore at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator
Related Tags: buy Seribantumab | purchase Seribantumab | Seribantumab cost | order Seribantumab | Seribantumab in vivo | Seribantumab in vitro | Seribantumab molecular weight